NGENF
NervGen Pharma Corp.

Bill Adams has over 25 years of strategic financial management experience that includes mergers and acquisitions, operations and capital markets in both Canada and the U.S., as well as corporate and operational finance having held a number of executive positions with high-growth technology and life sciences companies, including Chief Financial Officer roles at Anandia Laboratories Inc., Response Biomedical Corp., CellFor Inc., and AnorMED Inc. He had a leading role in the sale of AnorMED to Genzyme for $580 million and was instrumental in the sale of Anandia in 2018 for $118 million. Mr. Adams has been responsible for completing over $250 million in public and private equity financing, including listing on the TSX and NASDAQ, and over $750 million in mergers and acquisitions and technology licensing transactions. Mr. Adams is a Chartered Professional Accountant, CA and holds a Bachelor of Commerce from the University of British Columbia.

Brian Bayley is a Director and the Executive Chairman of Earlston Investments Corp. , a private Merchant Bank with transaction experience over $2b. Previously, Mr. Bayley was CEO of Quest Capital Corp. and worked with the Vancouver Stock Exchange, now the TSX Venture Exchange. Mr. Bayley has over 30 years of public issuer experience both as a director and officer in numerous private and public companies.

Dr. Kaye is currently Chief Medical Officer at Neurana Pharmaceuticals in San Diego, California. Prior to Neurana, Dr. Kaye served as CMO at Click Therapeutics, Axsome Therapeutics and Avanir Pharmaceuticals. Earlier in his career, Dr. Kaye held leadership positions at Scios Inc., InterMune and Pfizer Inc. Dr. Kaye earned an M.D., M.P.H. and B.S. at The George Washington University and was a Research Fellow at Harvard Medical School.

Dr. Punnett is an accomplished angel investor who has been the director of multiple startup companies. A co-founder of NervGen, he has a deep passion for helping those with spinal cord injury and nerve related challenges.